LAMIVUDINE

25273 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAMIVUDINE:

# Side effect Count
0 FOETAL EXPOSURE DURING PREGNANCY 2040
1 DRUG RESISTANCE 1960
2 VIROLOGIC FAILURE 1960
3 DRUG INTERACTION 1871
4 PATHOGEN RESISTANCE 1774
5 VIRAL MUTATION IDENTIFIED 1671
6 DEPRESSION 1343
7 PYREXIA 1279
8 DRUG INEFFECTIVE 1165
9 ANAEMIA 1126
See all common reactions for LAMIVUDINE

LAMIVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PINEALOBLASTOMA 75 0.8065
1 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 101 0.7829
2 CSF HIV VIRUS IDENTIFIED 18 0.7826
3 CONGENITAL NEOPLASM 21 0.7778
4 GENOTYPE DRUG RESISTANCE TEST 34 0.6939
5 CSF HIV ESCAPE SYNDROME 83 0.6014
6 HIV VIRAEMIA 115 0.5476
7 ULTRASOUND ANTENATAL SCREEN 52 0.5417
8 IMMUNE RECONSTITUTION SYNDROME 626 0.4849
9 VIRAL MUTATION IDENTIFIED 1671 0.4532
See all enriched reactions for LAMIVUDINE